Cottonwood Technology Fund

Cottonwood Technology Fund is a venture capital firm based in Santa Fe, New Mexico, founded in 2009. The firm specializes in early-stage investments, focusing on disruptive technologies across various sectors, including healthcare, nanotechnology, robotics, advanced materials, and clean energy. Cottonwood is particularly interested in patent-based high-tech and hardware startups, as well as opportunities in telecom and automotive industries. The firm primarily invests in the Southwestern United States, covering regions such as Arizona, New Mexico, Texas, Colorado, and Utah, with additional interests in Northern Europe, including the Netherlands. Investments typically range from $1 million to $3 million, and Cottonwood often seeks to take board seats in its portfolio companies to actively engage in their growth and development.

Avi Arora

Analyst

Sabine Bijker

Investor

Dave Blivin

Managing Partner

David Blivin

Founder and Managing Partner

Shinjan Dasgupta

Venture Partner

Karol Fels

Analyst

Michael Jackson

Partner

Alain le Loux MSc. MBA

General Partner

Matthew Ongaro

Partner

Lee Rand

Partner

Past deals in New Mexico

BioFlyte

Series A in 2022
BioFlyte specializes in the development of advanced bio-threat detection devices aimed at safeguarding against biological and low-volatility chemical threats. The company's innovative aerosol mass spectrometers are capable of autonomously sampling ambient air in critical environments, while also allowing for the manual analysis of liquid or powder samples. These instruments can identify a range of threats, including microbes, bio-toxins, and airborne chemicals, providing timely alerts to users about potential dangers. BioFlyte's technologies are designed to enhance safety and security by enabling effective responses to bio-chemical risks.

mPower Technology

Series B in 2022
mPower Technology, Inc. is a manufacturer of interconnected meshes of miniature solar cells, founded in 2014 and headquartered in Albuquerque, New Mexico. The company specializes in developing semiconductor active miniature solar cells tailored for the space, terrestrial, and Internet of Things (IoT) industries. By utilizing advanced materials and processes from the silicon photovoltaic and microelectronics sectors, mPower Technology provides a flexible solar solution that overcomes the limitations of traditional silicon and gallium arsenide solar cells. This innovation allows clients to enhance the performance and longevity of solar cells even in challenging environments, such as those encountered in space, where on-orbit radiation recovery is critical. The company's experienced team aims to advance solar power technology on a global scale.

Circular Genomics

Seed Round in 2021
Circular Genomics is a biotechnology company based in Albuquerque, New Mexico, focused on developing RNA-based diagnostic and therapeutic assays aimed at treating psychiatric and neurological diseases. Founded in 2021, the company specializes in circular RNA diagnostics, which provide an evidence-based approach to managing depressive disorders. This innovative technology significantly reduces the time required to achieve a therapeutic response in patients, allowing healthcare providers to more effectively diagnose and treat various psychiatric conditions. Through its advancements in RNA diagnostics, Circular Genomics seeks to enhance treatment outcomes for individuals suffering from these challenging illnesses.

BayoTech

Series C in 2021
BayoTech, Inc. is a company that specializes in the development and manufacturing of hydrogen generation systems and reformers, including steam methane reformers. Founded in 2015 and headquartered in Albuquerque, New Mexico, BayoTech focuses on creating hydrogen-based products for sectors such as agriculture, fuel cells, and energy. The company aims to centralize the hydrogen supply chain by establishing local hydrogen production hubs, offering a comprehensive portfolio that includes production, transport, storage, and fueling solutions. This approach allows BayoTech to provide reliable, cost-effective, and low-carbon hydrogen, making it accessible to various clients.

BennuBio

Series B in 2020
BennuBio, Inc. develops innovative flow cytometry equipment designed for cell sorting and analysis across various applications, including rare cell detection and monitoring. Their flagship product, The Velocyt, enables users to analyze rare events such as activated T cells, immune cells for personalized medicine, fetal cells from maternal blood, and circulating tumor cells. The company also offers spheroid generation systems and high-volume sorting systems, alongside technical support and application services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio aims to improve healthcare outcomes by providing advanced tools for cell counting, sorting, and biomarker detection, accommodating a wide range of sample volumes and particle sizes.

mPower Technology

Series A in 2020
mPower Technology, Inc. is a manufacturer of interconnected meshes of miniature solar cells, founded in 2014 and headquartered in Albuquerque, New Mexico. The company specializes in developing semiconductor active miniature solar cells tailored for the space, terrestrial, and Internet of Things (IoT) industries. By utilizing advanced materials and processes from the silicon photovoltaic and microelectronics sectors, mPower Technology provides a flexible solar solution that overcomes the limitations of traditional silicon and gallium arsenide solar cells. This innovation allows clients to enhance the performance and longevity of solar cells even in challenging environments, such as those encountered in space, where on-orbit radiation recovery is critical. The company's experienced team aims to advance solar power technology on a global scale.

BennuBio

Series A in 2018
BennuBio, Inc. develops innovative flow cytometry equipment designed for cell sorting and analysis across various applications, including rare cell detection and monitoring. Their flagship product, The Velocyt, enables users to analyze rare events such as activated T cells, immune cells for personalized medicine, fetal cells from maternal blood, and circulating tumor cells. The company also offers spheroid generation systems and high-volume sorting systems, alongside technical support and application services. Founded in 2018 and based in Albuquerque, New Mexico, BennuBio aims to improve healthcare outcomes by providing advanced tools for cell counting, sorting, and biomarker detection, accommodating a wide range of sample volumes and particle sizes.

BayoTech

Series B in 2018
BayoTech, Inc. is a company that specializes in the development and manufacturing of hydrogen generation systems and reformers, including steam methane reformers. Founded in 2015 and headquartered in Albuquerque, New Mexico, BayoTech focuses on creating hydrogen-based products for sectors such as agriculture, fuel cells, and energy. The company aims to centralize the hydrogen supply chain by establishing local hydrogen production hubs, offering a comprehensive portfolio that includes production, transport, storage, and fueling solutions. This approach allows BayoTech to provide reliable, cost-effective, and low-carbon hydrogen, making it accessible to various clients.

TriLumina

Venture Round in 2017
TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

Masterson Industries

Series A in 2015
Masterson Industries, LLC, established in 2012 and located in Albuquerque, New Mexico, specializes in the development and manufacturing of microgravity-enabled and semiconductor materials, including gallium nitride. The company has built a substantial portfolio of intellectual property and recently expanded its operations into a new production facility. Masterson Industries produces specialty materials that cater to various sectors, including defense, medical devices, electronics, and telecommunications. With a newly appointed sales and marketing team focused on these industries, the company is poised for commercial expansion and is currently preparing for a commercialization demonstration.

Skorpios Technologies

Series D in 2015
Skorpios Technologies, Inc., a fabless semiconductor company, develops and markets silicon photonic integrated circuit (IC) products. The company offers 100G-CWDM system-on-chip fully integrated opto-electronic S-roC receiver ICs and S-toC transmitter ICs. It also provides Skorpios’ Template Assisted Bonding, a platform to address various applications that include high-speed video, data, and voice communications for networking and cloud computing, storage, wireless, and cable TV; and Skorpios optical ASICs that are constructed from a set of photonic and electrical macrocell building blocks. The company serves to aerospace and defense, bioelectronics, and communications sectors. Skorpios Technologies, Inc. was founded in 2009 and is based in Albuquerque, New Mexico.

Raptor Products

Series A in 2015
Raptor Products Inc. specializes in manufacturing durable firearms accessories that prioritize security and accessibility for gun owners. The company offers innovative mounting and display solutions designed for a range of users, including home self-defense enthusiasts, tactical teams, law enforcement, and gun store owners. Utilizing military-grade materials such as polymer and stainless steel, Raptor Products' systems feature auto-locking technology that securely attaches to firearms via the Picatinny rail. This design not only ensures the safety of the firearms but also enhances the display options available to users, providing them with confidence in storing, staging, and showcasing their weapons.

TriLumina

Series B in 2015
TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

Respira Therapeutics

Convertible Note in 2015
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, established in 2010. The company specializes in the pulmonary delivery of therapeutics aimed at addressing respiratory diseases with unmet medical needs. Respira focuses on the development and commercialization of passive dry powder inhalers (DPIs) that utilize a novel drug delivery engine and mechanism of action for effective lung therapy. The company has achieved clinical proof-of-principle for its technology, which has demonstrated superior drug dispersion performance compared to existing devices. This positions Respira's DPIs to potentially replace currently marketed inhalation devices and expand inhaled therapies across various drug classes and disease indications, particularly in high-value therapeutic areas. Additionally, Respira maintains a strategic collaboration with United Therapeutics Corporation to further its objectives in this field.

Respira Therapeutics

Convertible Note in 2014
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, established in 2010. The company specializes in the pulmonary delivery of therapeutics aimed at addressing respiratory diseases with unmet medical needs. Respira focuses on the development and commercialization of passive dry powder inhalers (DPIs) that utilize a novel drug delivery engine and mechanism of action for effective lung therapy. The company has achieved clinical proof-of-principle for its technology, which has demonstrated superior drug dispersion performance compared to existing devices. This positions Respira's DPIs to potentially replace currently marketed inhalation devices and expand inhaled therapies across various drug classes and disease indications, particularly in high-value therapeutic areas. Additionally, Respira maintains a strategic collaboration with United Therapeutics Corporation to further its objectives in this field.

xF Technologies

Debt Financing in 2014
XF Technologies is a technology company that recycles renewable waste biomass into valuable products such as fuel, additives, petrochemical replacements, and specialty chemicals. Its molecular platform belongs to a family of chemicals called furaotes or simply 408s that provide similar or superior performance to the ingredients they intend to replace. In some cases, 408s can replace multiple ingredients in a formulation leading to significant cost savings. In other applications cost savings is a result of the total cost of ownership of the final product due to its improved environmental health and safety (EHS) rating. XF Technologies was founded in 2007 and is headquartered in Albuquerque, New Mexico.

TriLumina

Series A in 2014
TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

xF Technologies

Series A in 2014
XF Technologies is a technology company that recycles renewable waste biomass into valuable products such as fuel, additives, petrochemical replacements, and specialty chemicals. Its molecular platform belongs to a family of chemicals called furaotes or simply 408s that provide similar or superior performance to the ingredients they intend to replace. In some cases, 408s can replace multiple ingredients in a formulation leading to significant cost savings. In other applications cost savings is a result of the total cost of ownership of the final product due to its improved environmental health and safety (EHS) rating. XF Technologies was founded in 2007 and is headquartered in Albuquerque, New Mexico.

Skorpios Technologies

Series C in 2013
Skorpios Technologies, Inc., a fabless semiconductor company, develops and markets silicon photonic integrated circuit (IC) products. The company offers 100G-CWDM system-on-chip fully integrated opto-electronic S-roC receiver ICs and S-toC transmitter ICs. It also provides Skorpios’ Template Assisted Bonding, a platform to address various applications that include high-speed video, data, and voice communications for networking and cloud computing, storage, wireless, and cable TV; and Skorpios optical ASICs that are constructed from a set of photonic and electrical macrocell building blocks. The company serves to aerospace and defense, bioelectronics, and communications sectors. Skorpios Technologies, Inc. was founded in 2009 and is based in Albuquerque, New Mexico.

Masterson Industries

Series A in 2013
Masterson Industries, LLC, established in 2012 and located in Albuquerque, New Mexico, specializes in the development and manufacturing of microgravity-enabled and semiconductor materials, including gallium nitride. The company has built a substantial portfolio of intellectual property and recently expanded its operations into a new production facility. Masterson Industries produces specialty materials that cater to various sectors, including defense, medical devices, electronics, and telecommunications. With a newly appointed sales and marketing team focused on these industries, the company is poised for commercial expansion and is currently preparing for a commercialization demonstration.

Respira Therapeutics

Series A in 2013
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, established in 2010. The company specializes in the pulmonary delivery of therapeutics aimed at addressing respiratory diseases with unmet medical needs. Respira focuses on the development and commercialization of passive dry powder inhalers (DPIs) that utilize a novel drug delivery engine and mechanism of action for effective lung therapy. The company has achieved clinical proof-of-principle for its technology, which has demonstrated superior drug dispersion performance compared to existing devices. This positions Respira's DPIs to potentially replace currently marketed inhalation devices and expand inhaled therapies across various drug classes and disease indications, particularly in high-value therapeutic areas. Additionally, Respira maintains a strategic collaboration with United Therapeutics Corporation to further its objectives in this field.

xF Technologies

Series A in 2013
XF Technologies is a technology company that recycles renewable waste biomass into valuable products such as fuel, additives, petrochemical replacements, and specialty chemicals. Its molecular platform belongs to a family of chemicals called furaotes or simply 408s that provide similar or superior performance to the ingredients they intend to replace. In some cases, 408s can replace multiple ingredients in a formulation leading to significant cost savings. In other applications cost savings is a result of the total cost of ownership of the final product due to its improved environmental health and safety (EHS) rating. XF Technologies was founded in 2007 and is headquartered in Albuquerque, New Mexico.

VeriTran

Seed Round in 2013
VeriTran Inc., based in Albuquerque, New Mexico, specializes in the development of infinitely variable transmissions and power trains. Founded in 1998 by the inventors of its patented technology, the company produces compact belted drives designed for adjustable and variable speed applications, particularly for electric motors. VeriTran's products cater to a range of uses, including electric motor variable speed drives, engine-driven generators, small wind turbines, and automotive transmissions. The company has formed a strategic partnership with TEAM Technologies Inc. to enhance its offerings in the market.

TriLumina

Series A in 2013
TriLumina Corporation, established in 2010 and based in Albuquerque, New Mexico, specializes in manufacturing semiconductor lasers, particularly vertical-cavity surface-emitting lasers (VCSEL) for advanced illumination solutions. The company focuses on applications in 3D sensing and LiDAR technology, catering to automotive, industrial, and mobile markets. TriLumina's patented VCSEL innovations support the rapid development of next-generation technologies, making them a preferred choice for various applications, including augmented reality, virtual reality, 3D cameras, and autonomous vehicles. Their products are designed for integration into Time-of-Flight and Long Range LiDAR systems, as well as in-cabin applications, and have attained automotive Grade 1 temperature range AEC-Q102 qualification, ensuring high performance and reliability for clients in demanding environments.

xF Technologies

Series A in 2012
XF Technologies is a technology company that recycles renewable waste biomass into valuable products such as fuel, additives, petrochemical replacements, and specialty chemicals. Its molecular platform belongs to a family of chemicals called furaotes or simply 408s that provide similar or superior performance to the ingredients they intend to replace. In some cases, 408s can replace multiple ingredients in a formulation leading to significant cost savings. In other applications cost savings is a result of the total cost of ownership of the final product due to its improved environmental health and safety (EHS) rating. XF Technologies was founded in 2007 and is headquartered in Albuquerque, New Mexico.

Skorpios Technologies

Series B in 2011
Skorpios Technologies, Inc., a fabless semiconductor company, develops and markets silicon photonic integrated circuit (IC) products. The company offers 100G-CWDM system-on-chip fully integrated opto-electronic S-roC receiver ICs and S-toC transmitter ICs. It also provides Skorpios’ Template Assisted Bonding, a platform to address various applications that include high-speed video, data, and voice communications for networking and cloud computing, storage, wireless, and cable TV; and Skorpios optical ASICs that are constructed from a set of photonic and electrical macrocell building blocks. The company serves to aerospace and defense, bioelectronics, and communications sectors. Skorpios Technologies, Inc. was founded in 2009 and is based in Albuquerque, New Mexico.

Respira Therapeutics

Series A in 2010
Respira Therapeutics, Inc. is a drug development company based in Albuquerque, New Mexico, established in 2010. The company specializes in the pulmonary delivery of therapeutics aimed at addressing respiratory diseases with unmet medical needs. Respira focuses on the development and commercialization of passive dry powder inhalers (DPIs) that utilize a novel drug delivery engine and mechanism of action for effective lung therapy. The company has achieved clinical proof-of-principle for its technology, which has demonstrated superior drug dispersion performance compared to existing devices. This positions Respira's DPIs to potentially replace currently marketed inhalation devices and expand inhaled therapies across various drug classes and disease indications, particularly in high-value therapeutic areas. Additionally, Respira maintains a strategic collaboration with United Therapeutics Corporation to further its objectives in this field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.